Clinical trial on the effect of Resolvis on ocular surface diseases.
Completed
- Conditions
- dry eye
- Registration Number
- NL-OMON26119
- Lead Sponsor
- Medivis srl, c.so Italia 171, 95127 Catania
- Brief Summary
Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 Fatty acids for treatment of dry eye. Arch Ophthalmol 2008;126:219-225.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1. Symptoms of dry eye;
2. And at least 2 of the following:
Exclusion Criteria
1. Glaucoma;
2. Ocular surface infections;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increased stability of the tear film mesured by tear break-up time (BUT).
- Secondary Outcome Measures
Name Time Method Reduced symptoms (measured by means of a specific questionnaire, ocular surface disease index), and ocular surface signs and inflammation (measured by fluorescin and lissamine green staining of the ocular surface, HLA-DR expression) after treatment of dry eye.